Reviewed,
UniProtKB/Swiss-Prot P27953 (POLG_HCVE0)
Last modified
June 16, 2009.
Version 54.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Genome polyprotein Cleaved into the following 2 chains: 1- Recommended name: Envelope glycoprotein E1 Alternative name(s): gp32 gp35 2- Recommended name: Envelope glycoprotein E2 Alternative name(s): NS1 gp68 gp70 |
| Organism | Hepatitis C virus (isolate EC10) (HCV) |
| Taxonomic identifier | 11106 [NCBI] |
| Taxonomic lineage | Viruses › ssRNA positive-strand viruses, no DNA stage › Flaviviridae › Hepacivirus |
| Virus host | Homo sapiens (Human) [TaxID: 9606] |
Protein attributes
| Sequence length | 138 AA. |
| Sequence status | Fragment. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Inferred from homology. |
General annotation (Comments)
| Function | E1 and E2 glycoproteins form a heterodimer that is involved in virus attachment to the host cell, virion internalization through clathrin-dependent endocytosis and fusion with host membrane. E1/E2 heterodimer binds to human LDLR, CD81 and SCARB1/SR-BI receptors, but this binding is not sufficient for infection, some additional liver specific cofactors may be needed. The fusion function may possibly be carried by E1. E2 inhibits human EIF2AK2/PKR activation, preventing the establishment of an antiviral state. E2 is a viral ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on liver sinusoidal endothelial cells and macrophage-like cells of lymph node sinuses. These interactions allow capture of circulating HCV particles by these cells and subsequent transmission to permissive cells. DCs act as sentinels in various tissues where they entrap pathogens and convey them to local lymphoid tissue or lymph node for establishment of immunity. Capture of circulating HCV particles by these SIGN+ cells may facilitate virus infection of proximal hepatocytes and lymphocyte subpopulations and may be essential for the establishment of persistent infection By similarity. |
| Subunit structure | E1 and E2 glycoproteins form a heterodimer that binds to human LDLR, CD81 and SCARB1 receptors. E2 binds and inhibits human EIF2AK2/PKR. Also binds human CD209/DC-SIGN and CLEC4M/DC-SIGNR By similarity. |
| Subcellular location | Envelope glycoprotein E1: Virion membrane; Single-pass type I membrane protein Potential. Host endoplasmic reticulum membrane; Single-pass type I membrane protein By similarity. Note: The C-terminal transmembrane domain acts as a signal sequence and forms a hairpin structure before cleavage by host signal peptidase. After cleavage, the membrane sequence is retained at the C-terminus of the protein, serving as ER membrane anchor. A reorientation of the second hydrophobic stretch occurs after cleavage producing a single reoriented transmembrane domain. These events explain the final topology of the protein. ER retention of E1 is leaky and, in overexpression conditions, only a small fraction reaches the plasma membrane By similarity. Envelope glycoprotein E2: Virion membrane; Single-pass type I membrane protein Potential. Host endoplasmic reticulum membrane; Single-pass type I membrane protein By similarity. Note: The C-terminal transmembrane domain acts as a signal sequence and forms a hairpin structure before cleavage by host signal peptidase. After cleavage, the membrane sequence is retained at the C-terminus of the protein, serving as ER membrane anchor. A reorientation of the second hydrophobic stretch occurs after cleavage producing a single reoriented transmembrane domain. These events explain the final topology of the protein. ER retention of E2 is leaky and, in overexpression conditions, only a small fraction reaches the plasma membrane By similarity. |
| Domain | The transmembrane regions of envelope E1 and E2 glycoproteins are involved in heterodimer formation, ER localization, and assembly of these proteins. Envelope E2 glycoprotein contain two highly variable regions called hypervariable region 1 and 2 (HVR1 and HVR2) and two CD81-binding sites. HVR1 is implicated in the SCARB1-mediated cell entry. HVR2 and CD81-binding sites may be involved in sensitivity and/or resistance to IFN-alpha therapy By similarity. |
| Post-translational modification | Specific enzymatic cleavages in vivo yield mature proteins. The structural proteins E1 and E2 are produced by proteolytic processing by the host signal peptidases. Envelope E1 and E2 glycoproteins are highly N-glycosylated By similarity. |
| Miscellaneous | The virion of this virus is a nucleocapsid covered by a lipoprotein envelope. The envelope contains two proteins: the envelope glycoproteins E1 and E2. |
| Sequence similarities | Belongs to the hepaciviruses polyprotein family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Fusion protein Host-virus interaction |
| Cellular component | Endoplasmic reticulum Envelope protein Membrane Virion |
| Domain | Transmembrane |
| PTM | Glycoprotein |
| Gene Ontology (GO) | |
| Biological process | interspecies interaction between organisms Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | endoplasmic reticulum Inferred from electronic annotation. Source: UniProtKB-KW integral to membraneInferred from electronic annotation. Source: UniProtKB-KW viral envelopeInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | ‹1 – 84 | ›84 | Envelope glycoprotein E1 Potential | PRO_0000037553 | |||||
| Chain | 85 – ›138 | ›54 | Envelope glycoprotein E2 Potential | PRO_0000037554 | |||||
Regions | |||||||||
| Topological domain | ‹1 – 59 | ›59 | Lumenal Potential | ||||||
| Transmembrane | 60 – 80 | 21 | Potential | ||||||
| Topological domain | 81 – ›138 | ›58 | Lumenal Potential | ||||||
| Region | 86 – 112 | 27 | HVR1 By similarity | ||||||
Sites | |||||||||
| Site | 84 – 85 | 2 | Cleavage; by host signal peptidase Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 6 | 1 | N-linked (GlcNAc...); by host Potential | ||||||
| Glycosylation | 118 | 1 | N-linked (GlcNAc...); by host Potential | ||||||
| Glycosylation | 124 | 1 | N-linked (GlcNAc...); by host Potential | ||||||
| Glycosylation | 131 | 1 | N-linked (GlcNAc...); by host Potential | ||||||
Experimental info | |||||||||
| Non-terminal residue | 1 | 1 | |||||||
| Non-terminal residue | 138 | 1 | |||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins." Weiner A.J., Brauer M.J., Rosenblatt J., Richman K.H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q.-L., Houghton M., Han J.H. Virology 180:842-848(1991) [PubMed: 1846505] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA]. |
| [2] | "Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes." McLauchlan J. J. Viral Hepat. 7:2-14(2000) [PubMed: 10718937] [Abstract] Cited for: REVIEW. |
| [3] | "Structural biology of hepatitis C virus." Penin F., Dubuisson J., Rey F.A., Moradpour D., Pawlotsky J.-M. Hepatology 39:5-19(2004) [PubMed: 14752815] [Abstract] Cited for: REVIEW, SUBCELLULAR LOCATION. |
Cross-references
Sequence databases | |
|---|---|
| X53136 Genomic RNA. Translation: CAA37296.1. | |
3D structure databases | |
| ModBase | Search... |
Organism-specific databases | |
| euHCVdb | X53136. |
Family and domain databases | |
| InterPro | IPR002519. HCV_env. IPR002531. HCV_NS1. [Graphical view] |
| Pfam | PF01539. HCV_env. 1 hit. PF01560. HCV_NS1. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | POLG_HCVE0 | ||||||||
| Accession | Primary (citable) accession number: P27953 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | Virus (Virus annotation project) | ||||||||
Relevant documents
| SIMILARITY comments Index of protein domains and families |
| Recent format changes Overview of recent format changes |

Clusters with


